Gross Margin - Deciphera Pharmaceuticals Inc (F:D05) - Alpha Spread
D

Deciphera Pharmaceuticals Inc
F:D05

Watchlist Manager
Deciphera Pharmaceuticals Inc
F:D05
Watchlist
Price: 38.5 EUR 1.32% Market Closed
Market Cap: 3.2B EUR
Have any thoughts about
Deciphera Pharmaceuticals Inc?
Write Note

Gross Margin
Deciphera Pharmaceuticals Inc

97%
Current
96%
Average
63%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
97%
=
Gross Profit
169.6m
/
Revenue
174.9m

Gross Margin Across Competitors

Country US
Market Cap 3.1B EUR
Gross Margin
97%
Country US
Market Cap 341.9B USD
Gross Margin
67%
Country US
Market Cap 180.5B USD
Gross Margin
63%
Country US
Market Cap 129B USD
Gross Margin
87%
Country US
Market Cap 123.6B USD
Gross Margin
86%
Country US
Market Cap 104.5B USD
Gross Margin
77%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 142.3B AUD
Gross Margin
52%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country US
Market Cap 38.5B USD
Gross Margin
97%
Country US
Market Cap 35.4B USD
Gross Margin
87%

Profitability Report

View the profitability report to see the full profitability analysis for Deciphera Pharmaceuticals Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
97%
=
Gross Profit
169.6m
/
Revenue
174.9m
What is the Gross Margin of Deciphera Pharmaceuticals Inc?

Based on Deciphera Pharmaceuticals Inc's most recent financial statements, the company has Gross Margin of 97%.